Drug Shortage Report for LOSARTAN HCT

Last updated on 2020-08-04 History
Report ID 78886
Drug Identification Number 02388979
Brand name LOSARTAN HCT
Common or Proper name LOSARTAN HCT
Company Name SIVEM PHARMACEUTICALS ULC
Market Status DORMANT
Active Ingredient(s) HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM
Strength(s) 12.5MG 100MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-04-05
Actual start date 2019-04-08
Estimated end date
Actual end date 2019-08-30
Shortage status Resolved
Updated date 2020-08-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4705 DOBRIN STREET
SAINT-LAURENT, QUEBEC
CANADA H4R 2P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v29 2020-08-04 French Compare
v28 2020-08-04 English Compare
v27 2019-08-05 French Compare
v26 2019-08-05 English Compare
v25 2019-07-26 French Compare
v24 2019-07-26 English Compare
v23 2019-07-19 French Compare
v22 2019-07-19 English Compare
v21 2019-07-05 French Compare
v20 2019-07-05 English Compare
v19 2019-06-28 French Compare
v18 2019-06-28 English Compare
v17 2019-06-17 French Compare
v16 2019-06-17 English Compare
v15 2019-05-17 French Compare
v14 2019-05-17 English Compare
v13 2019-04-09 French Compare
v12 2019-04-09 English Compare
v11 2019-04-09 English Compare
v10 2019-04-09 French Compare

Showing 1 to 20 of 29